Corteva expands in gene editing

Article Excerpt

CORTEVA INC., $58.95, is a buy. The company (www.corteva.com; New York symbol CTVA; TSINetwork Rating: Extra Risk) (Shares o/s: 692.2 million; Market cap: $40.8 billion; Dividend yield: 1.2%) will now collaborate with Pairwise, a technology company aiming to pioneer the application of gene editing in food and agriculture. Gene editing uses a plant’s own DNA to make precise improvements, providing growers with another tool to keep pace with the challenges facing food production, including those presented by climate change. Corteva will make a $25 million equity investment in Pairwise. Corteva is a a buy. buy…